Previous 10 | Next 10 |
Avantor press release (NYSE:AVTR): Q1 Non-GAAP EPS of $0.38 beats by $0.02. Revenue of $1.95B (+8.9% Y/Y) beats by $20M. Shares +0.5%. For further details see: Avantor Non-GAAP EPS of $0.38 beats by $0.02, revenue of $1.95B beats by $20M
Avantor® Reports First Quarter 2022 Results PR Newswire Net sales of $1.95 billion , increase of 9.2%; organic net sales growth of 5.1% Net income of $190.4 million ; Adjusted EBITDA of $423.1 million Diluted GAAP EPS of $0.28 ; adjusted EP...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. A sharp spike in bond yields pressured growth stocks and ...
As Danaher (DHR) is set to kick off the earnings season of the makers of Life Sciences & Diagnostic Tools on Thursday, Bank of America analysts led by Derik de Bruin issued cautious views on the subsector, citing macro and geopolitical headwinds. The earnings season for the group com...
Avantor® to Report First Quarter 2022 Results and Host Earnings Call on April 29, 2022 PR Newswire RADNOR, Pa. , April 6, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customer...
Life sciences company Avantor (AVTR -3.7%) is trading lower after Citi downgraded the stock to Neutral from Buy, citing a limited opportunity for near-term topline growth and margin expansion, particularly in the second half of this year. The price target trimmed by more than a fifth to $38 p...
Halvorsen's 13F portfolio value decreased from $36.04B to $34.49B this quarter. The number of positions increased from 96 to 107. Viking Global added Twilio, Workday, and Aon plc while dropping Fidelity National Information Services and Snowflake. The top three positions are Ginkg...
Avantor® to Participate in KeyBanc Life Sciences and Medtech Investor Forum PR Newswire RADNOR, Pa. , March 8, 2022 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life ...
Dan Loeb's 13F portfolio value decreased from $18.32B to $14.33B this quarter. The number of positions decreased from 113 to 92. Third Point increased Amazon, RH, and Catalent while decreasing Upstart Holdings and Walt Disney during the quarter. The top three positions are at ~23%...
Avantor sells products and services to the biopharma, healthcare, education, government, and advanced technologies & applied materials industries. In my view, what really matters is that Avantor expects $1 billion FCF, positive adjusted EPS close to $1.4-$1.5, and an EBITDA margin...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 07:15:06 ET Barclays analyst issues OVERWEIGHT recommendation for AVTR on July 29, 2024 05:42AM ET. The previous analyst recommendation was Overweight. AVTR was trading at $25.6 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
Bogota Financial Corp. (BSBK) is expected to report for Q2 2024 Capital Product Partners L.P. (CPLP) is expected to report $0.17 for Q2 2024 Colgate-Palmolive Company (CL) is expected to report $0.87 for Q2 2024 ARCA biopharma Inc. (ABIO) is expected to report for Q2 2024 Barnes G...
Avantor® Reports Second Quarter 2024 Results PR Newswire Net sales of $1.70 billion , decrease of 2.4%; organic decline of 2.0% Net income of $93 million ; Adjusted EBITDA of $306 million Diluted GAAP EPS of $0.14 ; adjusted EPS of $0.25 Op...